Predict your next investment

Corporation
HEALTHCARE | Biotechnology
nalpropion.com

See what CB Insights has to offer

Founded Year

2018

Stage

Acquired | Acquired

About Nalpropion Pharmaceuticals

Nalpropion Pharmaceuticals is a biopharmaceutical company focused on the treatment of weight loss.

Nalpropion Pharmaceuticals Headquarter Location

United States

Latest Nalpropion Pharmaceuticals News

Weight Loss and Obesity Management Market Complete Analytical Report for 2028 with Key Players- Allurion Technologies Inc., Nalpropion Pharmaceuticals, Inc., Beijing Noble Laser Technology Co., Ltd, and Others

Jun 11, 2021

Search jobs 11-Jun-2021 Weight Loss and Obesity Management Market Complete Analytical Report for 2028 with Key Players- Allurion Technologies Inc., Nalpropion Pharmaceuticals, Inc., Beijing Noble Laser Technology Co., Ltd, and Others A recent market study published by the company – “Weight Loss and Obesity Management: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2028,” consists of a comprehensive assessment of the most important market dynamics. By conducting a thorough research on the historical as well as current growth parameters of the weight loss and obesity management market, the growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may have a huge impact on the development of the weight loss and obesity management market during the forecast period. It can help the players to modify their manufacturing and marketing strategies to envisage maximum growth in the weight loss and obesity management in the upcoming years. The report provides detailed information about the current and future growth prospects of the weight loss and obesity management market in the most comprehensive way for better understanding of the readers. Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-411 Chapter 1 – Executive Summary The report commences with the executive summary of the weight loss and obesity management market, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the weight loss and obesity management market. Chapter 2 – Market Overview Readers can find detailed taxonomy and the definition of the weight loss and obesity management market in this chapter, which helps understand the basic information about the weight loss and obesity management. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the weight loss and obesity management market report. Chapter 3 – Key Success Factors This chapter highlights the key success factors of the weight loss and obesity management market report, which include regulatory scenario for medical devices and drugs, pipeline assessment of drugs for obesity, potential of anti-obesity drugs in the market, entry strategies, white space analysis, and list of key manufacturers. The key regulations section of this chapter highlights the FDA and EMA regulatory processes for the approval of drugs and devices. Chapter 4 – Global Weight Loss and Obesity Management Market – Pricing Analysis This section highlights the average price of laser assisted liposuction devices, radio frequency assisted liposuction devices, ultrasound assisted liposuction devices, bariatric stapling devices, gastric band, gastric balloon systems, gastric emptying systems, and gastric electrical stimulation systems in the different region throughout the globe. The pricing benchmark for manufacturer level pricing and distributor level pricing is analysed in this section. Chapter 5 – Global Weight Loss and Obesity Management Market Demand (in Value or Size in US$ Mn) Analysis 2013-2017 and Forecast, 2018-2028 This section explain the global market value analysis and forecast for the weight loss and obesity management market between the forecast periods of 2013-2028 is highlights in this section. Chapter 6 – Market Background This chapter explains the key macro-economic factors that are expected to influence the growth of the weight loss and obesity management market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the weight loss and obesity management market. This chapter also highlights the key market dynamics of the weight loss and obesity management market, which include the drivers, restraints and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the weight loss and obesity management market. Chapter 7 – Global Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028, By Product Type Based on the product type, the weight loss and obesity management market is segmented into drugs and devices. The drugs segment is further segmented into GLP-1 receptor agonists, lipase inhibitors, serotonin receptor agonist, combination drug, and others. The devices segment is further segmented into liposuction devices, bariatric stapling devices, gastric band, gastric balloon systems, gastric emptying systems, and gastric electrical stimulation systems. In this chapter, readers can find information about the key trends and developments in the weight loss and obesity management market and market attractive analysis based on the type of products. Chapter 8 – Global Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028, By Distribution Sales Based on the distribution sales, the weight loss and obesity management market is segmented into institutional sales and retail sales. Intuitional sales is further segmented into Hospitals, Weightloss Clinics, and Ambulatory Surgery Centers. Retail sales is segmented into retail pharmacies, drug stores, and online sales. In this chapter, the readers can find information about the key trends and developments in the weight loss and obesity management market and market attractive analysis based on distribution sales. Chapter 9 – Global Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028, By Region This chapter explains how the weight loss and obesity management market will grow across various geographic regions, such as North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa (MEA), and emerging countries. Chapter 10 – North America Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028 This chapter includes a detailed analysis of the growth of the North America weight loss and obesity management market along with a country-wise assessment including the U.S. and Canada. Readers can also find market growth based on product type, distribution sales, and country for the weight loss and obesity management market in North America. Chapter 11 – Latin America Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028 This chapter contains a snapshot of the Latin America weight loss and obesity management market. It includes the growth prospects of the weight loss and obesity management market in the leading LATAM countries such as Brazil, Mexico, and the rest of the Latin America region. Chapter 12 – Europe Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028 The important growth prospects of the weight loss and obesity management market based on its product type, and distribution sales in several European countries, such as the U.K., Germany, France, Italy Spain, Russia and the rest of Europe, is included in this chapter. Chapter 13 – South Asia Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028 India, Indonesia, Thailand , Malaysia are the leading countries in the South Asia region that are the prime subjects of assessment to obtain the growth prospects of the South Asia weight loss and obesity management market in this chapter. Readers can find detailed information about the growth parameters of the South Asia weight loss and obesity management market during the period 2018-2028. Chapter 14 – East Asia Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028 This chapter highlights the growth of the weight loss and obesity management market in the East Asia by focusing on China, Japan and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the weight loss and obesity management market in East Asia. Chapter 15 – Oceania Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028 Readers can find important factors that can significantly impact the growth of the weight loss and obesity management market in Australia and New Zealand during the forecast period based on the market segmentation. Chapter 16 – Middle East and Africa Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028 This chapter provides information about the growth of the weight loss and obesity management market in the major countries of the MEA region, such as GCC Countries, Turkey and South Africa, during the period 2018-2028. Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-411 Chapter 17 – Emerging Countries Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028 Readers can find important factors that can significantly impact the growth of the weight loss and obesity management market in emerging countries like China, India, and Brazil during the forecast period based on the market segmentation. Chapter 18 – Competition Landscape In this chapter, readers can find a comprehensive list of all the leading manufacturers in the weight loss and obesity management market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the players featured in the weight loss and obesity management market report are Novo Nordisk A/S, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Allergan Plc, Johnson & Johnson Services, Inc, Medtronic plc., Vivus Inc., Eisai Co., Ltd., ReShape Lifesciences, Inc, Obalon Therapeutics, Aspire Bariatrics, Allurion Technologies Inc., Nalpropion Pharmaceuticals, Inc., Beijing Noble Laser Technology Co., Ltd, and others. Chapter 19 – Assumptions and Acronyms This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report. Chapter 20 – Assumptions and Acronyms This chapter helps readers understand the research methodology followed to obtain various conclusions and important qualitative information & quantitative information about the weight loss and obesity management market. Explore Wide-ranging Coverage of FMI’s HealthcareLandscape Transradial Closure Devices Market – According to Future Market Insights (FMI), the demand from hospitals,independent catheterization centers, and healthcare clinics will continuerising. Spurred by this, the global transradial closure devices market is setto grow by 6.5% CAGR during the forecast period from the year 2020 to 2030. In Vitro FertilizationBanking Services Market – The in vitro fertilization banking servicesmarket, despite undergoing a temporary period of lull due to COVID-19 outbreak,is likely to have an impressive growth trajectory between 2020 and 2030. Cryopreservationfor In-vitro Fertilization (IVF) Market – According to analysis by Future Market Insights (FMI), cryopreservationfor IVF market surpassed a valuation of US$ 339 million in 2019. Themarket is set to reflect an impressive 10.2% CAGR through 2030. About FMI        Future Market Insights (FMI) is a leading provider of marketintelligence and consulting services, serving clients in over 150countries. FMI  isheadquartered in Dubai, the global financial capital, and has delivery centersin the U.S. and India. FMI’s latest  marketresearch reports  and industry analysis help businesses navigatechallenges and make critical decisions with confidence and clarity amidstbreakneck competition. Our customized and syndicated market research reportsdeliver actionable insights that drive sustainable growth. A team of expert-ledanalysts at FMI continuously tracks emerging trends and events in a broad rangeof industries to ensure that our clients prepare for the evolving needs oftheir consumers. ContactUs

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Nalpropion Pharmaceuticals Patents

Nalpropion Pharmaceuticals has filed 17 patents.

The 3 most popular patent topics include:

  • Phenols
  • Diabetes
  • Morphinans
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/14/2019

6/15/2021

Psychiatric diagnosis, Abnormal psychology, Depression (psychology), Antidepressants, Mood disorders

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

6/14/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

6/15/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Psychiatric diagnosis, Abnormal psychology, Depression (psychology), Antidepressants, Mood disorders

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.